Sabra Healthcare REIT, Inc. $SBRA Shares Sold by LGL Partners LLC

LGL Partners LLC trimmed its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 79.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,145 shares of the real estate investment trust’s stock after selling 40,000 shares during the quarter. LGL Partners LLC’s holdings in Sabra Healthcare REIT were worth $198,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in SBRA. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Sabra Healthcare REIT by 6.8% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after buying an additional 203,226 shares during the last quarter. Principal Financial Group Inc. boosted its position in Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Sabra Healthcare REIT by 7.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after acquiring an additional 269,793 shares during the period. Legal & General Group Plc lifted its stake in shares of Sabra Healthcare REIT by 16.5% during the 4th quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after purchasing an additional 201,667 shares during the period. Finally, Lasalle Investment Management Securities LLC purchased a new position in Sabra Healthcare REIT during the fourth quarter worth about $66,938,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $20.39 on Tuesday. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $22.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The company has a market capitalization of $5.21 billion, a price-to-earnings ratio of 78.43, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The firm’s fifty day moving average price is $20.47 and its 200 day moving average price is $20.17.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The firm had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business’s quarterly revenue was up 24.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.38 earnings per share. On average, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio is currently 461.54%.

Analysts Set New Price Targets

A number of research firms recently issued reports on SBRA. Robert W. Baird boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday. Barclays increased their price target on shares of Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday. Truist Financial increased their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, Citizens Jmp boosted their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research note on Wednesday, July 22nd. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Sabra Healthcare REIT has an average rating of “Hold” and a consensus target price of $22.17.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.